Cargando…
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
BACKGROUND: Cancer patients particularly those with hematological malignancies are at higher risk of affecting by severe coronavirus disease 2019 (COVID-19). Due to the immunocompromised nature of the disease and the immunosuppressive treatments, they are more likely to develop less antibody protect...
Autores principales: | Noori, Maryam, Azizi, Shadi, Abbasi Varaki, Farhan, Nejadghaderi, Seyed Aria, Bashash, Davood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273573/ https://www.ncbi.nlm.nih.gov/pubmed/35843148 http://dx.doi.org/10.1016/j.intimp.2022.109046 |
Ejemplares similares
-
Efficacy and safety of immune checkpoint inhibitors for patients with prostate cancer: a systematic review and meta-analysis
por: Noori, Maryam, et al.
Publicado: (2023) -
How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels?
por: Noori, Maryam, et al.
Publicado: (2021) -
Predictive value of PD-L1 expression in response to immune checkpoint inhibitors for esophageal cancer treatment: A systematic review and meta-analysis
por: Noori, Maryam, et al.
Publicado: (2022) -
A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?
por: Davoodi-Moghaddam, Zeinab, et al.
Publicado: (2023) -
Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
por: Esmaeili, Shadi, et al.
Publicado: (2021)